Employing its proprietary PDPS Technology, a state-of-the-art highly versatile discovery platform for new drugs
PeptiDream employs its proprietary Peptide Discovery Platform System (PDPS) technology, which then can be developed into peptide-based, small molecule-based, peptide-drug conjugate (PDC), and multi-functional peptide conjugates (MPC)-based therapeutics and diagnostics. PeptiDream has an extensive global network of discovery and development partners driving the development and commercialization of a broad and diversified pipeline of investigational therapeutics. PeptiDream also markets and sells a number of radiopharmaceutical and radiodiagnostic products in Japan, through its wholly owned subsidiary, PDRadiopharma.
Drug Discovery/Drug Discovery Support